January 20, 2021
The Business Journals: Washington, D.C.
Abalos Therapeutics is a biotechnology company that develops drugs for tumors and cancer. Read more
Abalos Therapeutics is a biotechnology company that develops drugs for tumors and cancer. Read more
CEO
Marcus Kostka
Agenus is one of Abalos Therapeutics's top competitors. Agenus was founded in 1994, and its headquarters is in Lexington, Massachusetts. Agenus competes in the Biotechnology field. Agenus has 293 more employees than Abalos Therapeutics.
January 20, 2021
The Business Journals: Washington, D.C.
January 21, 2021
Global University Venturing
No recent acquisitions found related to Abalos Therapeutics
Since Abalos Therapeutics was founded in 2019, it has participated in 1 round of funding. In total Abalos Therapeutics has raised $13.0M. Abalos Therapeutics' funding round was on Oct 2019 for a total of $13.0M
Since Abalos Therapeutics was founded in 2019, it has participated in 1 round of funding. In total Abalos Therapeutics has raised $13.0M. Abalos Therapeutics' funding round was on Oct 2019 for a total of $13.0M
No recent investments found related to Abalos Therapeutics